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Abstract Despite frequent reports on the presence of
Blastocystis hominis in human intestinal tract, its pathoge-
nicity remains a matter of intense debate. These discrep-
ancies may be due to the varying pathogenic potential or
virulence of the isolates studied. The present study
represents the first to investigate both phenotypic and
genotypic characteristics of B. hominis obtained from
symptomatic and asymptomatic individuals. Symptomatic
isolates had a significantly greater size range and lower
growth rate in Jones’ medium than asymptomatic isolates.
The parasite cells of symptomatic isolates exhibited rougher
surface topography and greater binding affinity to Canava-
lia ensiformis (ConA) and Helix pomatia (HPA). The
present study also identifies further phenotypic character-
istics, which aided in differentiating the pathogenic forms
from the non-pathogenic forms of B. hominis. Blastocystis
subtype 3 was found to be correlated well with the disease.
Introduction
Despite being discovered more than 90 years ago, the
pathogenicity of Blastocystis hominis has not been conclu-
sively determined, although it remains one of the most
common intestinal protozoan parasites of humans. The
possibility that virulent and avirulent isolates of Blastocystis
exist, or that pathogenicity is due to different species of
Blastocystis has been often suggested because B. hominis is
antigenically and genetically heterogeneous both within and
among geographic regions (Tan et al. 2002). In vitro,
Blastocystis can exhibit diverse morphologies and reproduc-
tive processes (Suresh et al. 2003), but whether different life
cycle stages influence pathogenicity remains to be elucidat-
ed. A review of the literature reveals that certain researchers
implicate B. hominis as a pathogen while others think
otherwise. The discrepancies may, in part, be due to the fact
that different researchers studied distinct Blastocystis iso-
lates, which had varying pathogenic potential (Clark 1997).
Recent studies investigating the pathogenic potential of
Blastocystis in humans have focused on genotypic analysis
(e.g. Böhm-Gloning et al. 1997; Kaneda et al. 2001;
Yoshikawa et al. 2004; Yan et al. 2006; Stensvold et al.
2007a,b) without providing phenotypic information on the
isolates studied. Therefore, no comparisons of phenotypic
similarities or differences can be made between the isolates
that these researchers subtyped. As current genotyping
methods cannot discriminate between symptomatic and
asymptomatic isolates, an obvious approach would be to
investigate the use of both phenotypic and genotypic
approaches to determining pathogenicity. Here, we investi-
gate both phenotypic and genotypic perspectives of B.
hominis isolates obtained from symptomatic and asymp-
tomatic individuals in order to determine whether such an
approach can assist in determining pathogenicity.
Materials and methods
Source of Blastocystis hominis isolates
A total of 20 human-derived B. hominis isolates, comprising
ten asymptomatic (A1–A10) and ten symptomatic (S1–S10)
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isolates were investigated. Both inclusion criteria and details
of the subjects, together with their clinical histories have
been described previously (Tan and Suresh 2006a).
Culture of B. hominis isolates
Parasites were isolated from clinical cases and healthy
individuals by in vitro cultivation in Jones’ medium (Jones
1946) supplemented with 10% horse serum at 37°C
(Suresh et al. 1994; Zaman 1997; Suresh and Smith
2004). A stool sample the size of a pea (500 mg–1 g) was
comminuted in 3 ml of Jones’ medium. For liquid stools,
about 750 μl was mixed with 3 ml of Jones’ medium.
Subsequently, parasites were maintained in Jones’ medium
by subculturing every 3 to 4 days for at least 1 month prior
to phenotypic analyses.
Growth characteristics
Parasites from 3-day-old cultures of each isolate were
grown separately at a final concentration of 1×104 cells per
ml in 3 ml of fresh Jones’ medium containing 10% horse
serum. All experiments were performed in triplicate. Para-
sites were enumerated daily for up to 10 days using an
improved Neubauer hemocytometer chamber (Hausser
Scientific) with 0.5% Trypan blue solution as an indicator
of viability (Fauque et al. 2007). Only viable cells that
excluded Trypan blue were enumerated. The generation
time (GT) was calculated for the 24-h period during which
the most rapid growth occurred, according to the formula
described by Zierdt and Swan (1981). Fifty parasites were
randomly selected from each culture for size measurement
every 48 h for up to 10 days, after their initial inoculation in
Jones’ medium and the percentages of vacuolar, granular
and amoeboid forms were calculated daily. Statistical
analyses were carried out using SPSS version 11.
Scanning electron microscopy
Three asymptomatic isolates (A1, A3 and A4) and three
symptomatic isolates (S1, S8 and S10) were selected
randomly for ultrastructural studies. The contents of the
day-5 culture (peak parasite count, see Fig. 1) were washed
five times with phosphate-buffered saline (PBS, 150 mM,
pH 7.4) and centrifuged (500×g, 5 min). Pelleted cells were
fixed in 4% glutaraldehyde then post-fixed in 1% osmium
tetroxide. Post-fixed specimens were mounted on polycar-
bonate membranes (Nucleopore, Agar Scientific, USA) and
dehydrated through increasing concentrations (10%, 20%,
30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 10 min each)
of ethanol, critical-point dried with carbon dioxide, coated
with gold, and examined in a scanning electron microscope
(Philips SEM 515).
Fluorescent lectin labeling of surfaces of symptomatic
and asymptomatic isolates
Six asymptomatic isolates (Isolates A1, A3, A4, A5, A6
and A7) and six symptomatic isolates (Isolates S1, S3, S4,
S5, S8 and S10) were randomly selected for surface
carbohydrate analysis. Parasites were cultivated in Jones’
medium as previously described. The parasites of the day-5
cultures of each isolate (peak parasite count, see Fig. 1)
were harvested and subjected to fluorescein isothiocyanate
(FITC)-lectin assays using three different lectins (Sigma,
USA): Canavalia ensiformis (FITC-ConA), Helix pomatia
(FITC-HPA) and Triticum vulgaris (FITC-WGA).
FITC-labelled lectins were reconstituted in phosphate-
buffered saline (PBS) pH 7.4 and dispensed in a total
volume of 50 μl in 1.5-ml microtubes (Eppendorf,
Germany). Parasite sediments from day 5 cultures were
washed twice (500×g, 10 min) with PBS and diluted to a
concentration of 2×107 cells/ml. B. hominis cells were
added to each FITC-lectin solution to a final volume of
100 μl. The mixture was incubated for 30 min at 37°C and
subsequently centrifuged and washed twice (500×g,
10 min) with PBS. The pellets were reconstituted in 50 μl
of PBS and 10 μl aliquots were examined by epifluor-
escence microscopy (Leitz, Wetzlar, Germany) at ×400
magnification. All experiments were performed in dupli-
cate. The results of the FITC-lectin assays were quantitated
with regard to: (1) percentage of fluorescent cells in 100
cells; (2) visual intensity of fluorescence (scale of bright-
ness 0, 1+, 2+, 3+).
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Fig. 1 Growth profiles of asymptomatic (A1–A10) and symptomatic
(S1–S10) isolates of B. hominis in Jones’ medium containing 10%
horse serum and incubated at 37°C. Asymptomatic isolates grew more
rapidly than symptomatic isolates. Note: S7 died on day 9 while S8
and S10 died on day 10
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Subtyping B. hominis isolates
All 20 B. hominis isolates were subjected to sequenced-
tagged site (STS) primer-polymerase chain reaction (PCR)
using the seven sets of primers previously described by
Yoshikawa et al. (2004). Parasites grown in Jones’ medium
were harvested by centrifugation (500×g, 5 min) and
washed six times with sterile PBS. Pellets were lysed in
lysis buffer (20 mM Tris–HCl buffer, pH 8.0, 100 mM
NaCl, 25 mM ethylenediaminetetraacetic acid (EDTA),
pH 8.0) containing 1% sodium dodecyl sulfate (SDS) and
0.5 mg proteinase K per milliliter (Fermentas, USA) and
incubated at 55°C overnight. Genomic DNA was extracted
with phenol/chloroform/isoamyl alcohol. Nucleic acids
were precipitated with 0.3 M sodium acetate, pH 5.2 (final
concentration) and two volumes of ice-cold ethanol.
Following washing in 70% ice-cold ethanol, the DNA
pellet was resuspended in 20–50 μl Tris–EDTA (TE) buffer
containing 10 mM Tris and 1 mM EDTA, pH 8.0.
Two to five microliters of DNA preparations were used
to amplify the genomic sequences in a 25-μl reaction
containing 0.2 mM of the four deoxyribonucleotide
triphosphates, 25 pmol of each primer, 1× PCR buffer
(75 mM Tris–HCl, pH 8.8, 20 mM (NH4)2SO4 and 0.01%
Tween 20), 2.5 mM MgCl2 and 1 U Taq DNA polymerase
(recombinant) (Fermentas, USA). PCR conditions consisted
of one cycle of initial denaturing at 94°C for 3 min,
followed by 30 cycles including denaturing at 94°C for
30 s, annealing at 57°C for 30 s and extension at 72°C for
1 min and an additional cycle with a 10-min chain
elongation at 72°C (thermocycler Eppendorf, Germany).
The amplified products were electrophoresed in 1.5%
agarose gels (Promega, USA) in Tris–borate-EDTA buffer.
Gels were stained with ethidium bromide and photographed
using an ultraviolet gel documentation system (Uvitec,
United Kingdom). PCR amplification for each primer pair
was repeated three times for each isolate.
Results
Growth characteristics
Over a 10-day period of cultivation in Jones’ medium
supplemented with 10% horse serum, asymptomatic iso-
lates (A1–A10) showed higher growth rates than symp-
tomatic isolates (S1–S10) (Fig. 1). Parasite counts for
asymptomatic isolates peaked on day 5 for A3, A5, A6 and
A10; day 6 for A1 and A9; and day 7 for A2, A4, A7 and
A8. From initial parasite counts of 1×104 cells/ml, peak
counts for asymptomatic isolates ranged from 1.33×106
cells/ml for A8 to 4.22×106 cells/ml for A4 (Fig. 1). Most
symptomatic isolates reached maximum parasite counts on
day 5 (S1, S2, S4, S8 and S10) and the peak parasite counts
ranged from 2.82×105 cells/ml (S7) to 5.64×105 cells/ml
(S9) (Fig. 1).
The generation time and number of generations per
24 h for all isolates are shown in Table 1. In the 20
isolates studied, the average generation time was 12.3±
4.3 h and the number of generations per 24 h averaged
2.2±0.7. Generally, asymptomatic isolates grew more
rapidly (average generation time 9.3 h) than symptomatic
isolates (average generation time 15.3 h). Isolate A2
showed the highest growth rate while S3 showed the
slowest growth rate. At the period of maximum growth,
asymptomatic isolates showed significantly lower genera-
tion time (higher growth rate) than symptomatic isolates
(p<0.05, Mann–Whitney test).
The size ranges of the various morphological forms of
Blastocystis were as follows: vacuolar=5 to 90 μm;
granular=10 to 35 μm and amoeboid=5 to 65 μm. Para-
sites from symptomatic isolates (S1–S10) were larger
(mean=19.3–26.8 μm) with greater size variations (SD=
8.3–14.2 μm) than parasites from asymptomatic isolates
(A1–A10) (mean=12.6–20.0 μm; SD=3.8–6.6 μm). The
Table 1 Generation time and number of generations per 24 h
recorded for asymptomatic (A1–A10) and symptomatic (S1–S10) B.
hominis isolates
Isolates Period of maximum
growth (days)
Generation
time (h)a
Number of
generationsa
A1 3–4 11.7 2.1
A2 1–2 6.9 3.5
A3 1–2 7.5 3.2
A4 1–2 7.8 3.1
A5 1–2 8.4 2.9
A6 1–2 9.8 2.5
A7 1–2 9.4 2.6
A8 1–2 11.1 2.2
A9 2–3 10.8 2.2
A10 1–2 9.5 2.5
Mean ± SD 9.3±1.6 2.7±0.5
S1 1–2 14.7 1.6
S2 1–2 13.0 1.8
S3 1–2 26.7 0.9
S4 2–3 12.3 2.0
S5 1–2 14.7 1.6
S6 1–2 13.1 1.8
S7 1–2 14.6 1.6
S8 1–2 15.7 1.5
S9 2–3 13.5 1.8
S10 2–3 14.8 1.6
Mean ± SD 15.3±4.1 1.6±0.3
a The generation time and number of generations were determined for
the 24-h period during which the most rapid growth occurred (see
Fig. 1).
SD standard deviation.
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median value for size also varied between each isolate. The
median value of the symptomatic (S1–S10) isolates ranged
from 17.5 to 25.0 μm, but the asymptomatic isolates (A1–
A10) exhibited smaller values of 12.5 to 20.0 μm. Isolate
S3 had the largest mean size (26.8 μm), while A5 had the
smallest (12.6 μm). Some overlap in size was observed
between symptomatic and asymptomatic isolates. Symp-
tomatic isolates showed a significantly greater size range
(42.5 to 85 μm) than asymptomatic isolates (17.5 to 30 μm)
(p<0.05, Mann–Whitney test; Fig. 2). The maximum size
was noted in S10 (85 μm) and the minimum in A2
(17.5 μm).
Scanning electron microscopy
Asymptomatic isolates (A1, A3 and A4) generally
appeared spherical and possessed a smooth surface with
tiny pores (Fig. 3a,b). In contrast, two populations of
parasites were observed in symptomatic isolates (S1, S8
and S10), namely, (1) spherical parasites with a rough,
highly convoluted surface (Fig. 4a,b), and (2) irregularly
shaped (amoeboid) parasites with large pseudopodia,
projections and deep indentations. The surface of amoe-
boid forms appeared fibrillar in nature. The surface coat of
symptomatic isolates, particularly amoeboid forms,
appeared to be more frequently associated with bacteria
(data not shown).
Surface coat carbohydrate reactivity
Symptomatic isolates consistently fluoresced more intense-
ly (2+ to 3+) with FITC-ConA and FITC-HPA than
asymptomatic isolates (1+) (Table 2). FITC-HPA fluores-
cence was more intense than FITC-ConA and FITC-WGA.
FITC-WGA did not bind to A1, A3, A4, A7, S1 and S10.
Isolates S4, S5 and S8 were agglutinated by FITC-HPA
(Fig. 5).
Subtyping B. hominis isolates
Using sequenced-tagged site primer-PCR, distinct PCR
products of the expected sizes were produced for each
particular subtype. Only subtypes 1, 2 and 3 were
encountered in the present study (Fig. 6). All symptomatic
isolates belonged to subtype 3 and all asymptomatic
isolates were subtype 1, except A8, which was subtype 2.
Discussion
The recent surge of interest in B. hominis biology has been
driven by the unresolved controversy concerning its role in
pathogenicity. Several studies have attempted to differenti-
ate symptomatic and asymptomatic isolates of B. hominis
based on phenotypic characteristics such as isoenzyme
patterns (Mansour et al. 1995; Gericke et al. 1997),
serogroups (Müller 1994) and protein profiles (Kukoschke
and Müller 1991; Lanuza et al. 1999) or genotypic
characteristics such as molecular profiles and subtype
signatures (Böhm-Gloning et al. 1997; Kaneda et al.
2001; Yoshikawa et al. 2004; Yan et al. 2006; Stensvold
et al. 2007a,b,c). As yet, the use of both phenotypic and
genotypic approaches to determining pathogenicity of the
isolates studied has not been reported. The present study
represents the first comparative study of both phenotypic
and genotypic characteristics of asymptomatic and symp-
tomatic human-derived B. hominis isolates.
In vitro culture of Blastocystis provides sufficient
organisms for assessing phenotypic differences between
isolates but has been subject to criticism in that it might
preferentially amplify specific Blastocystis subtypes. Parkar
et al. (2007) stated that in vitro culture of stool samples
prior to PCR favored the preferential amplification of
Blastocystis subtype 5 over subtype 1; however, Stensvold
et al. (2007a) compared data obtained from DNA ex-
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Fig. 2 Comparison of size
range between asymptomatic
(A1–A10) and symptomatic
(S1–S10) B. hominis isolates.
Symptomatic isolates have a
significantly greater size range
than the asymptomatic isolates
(p<0.05, Mann–Whitney test)
88 Parasitol Res (2008) 104:85–93
tracted directly from faeces and DNA extracted from 5-
and 28-day-old in vitro cultures of ten randomly chosen
Blastocystis isolates and demonstrated no differences,
indicating that in vitro culture had little or no impact on
subtype distribution or variation within a given specimen.
Given the limited data available, the fact that in vitro
culture had little or no impact on subtype distribution or
variation over time led us to the conclusion that in vitro
culture was a suitable method to use for this study.
As most growth profile studies and morphological
analyses of B. hominis have been performed on small
sample sizes and mostly on either symptomatic or asymp-
tomatic isolates, or isolates without clinical histories, the
relationships between B. hominis in vitro growth character-
istics and morphology and its pathogenic potential, as
determined by clinical and molecular subtyping criteria,
have not been examined.
In the present study, two different groups of B. hominis
isolates that could be differentiated in terms of their
morphology were identified. Asymptomatic isolates had a
smaller size range, a greater abundance of granular forms
and multiplied more rapidly in Jones’ medium. In contrast,
all symptomatic isolates exhibited a greater size range, the
presence of amoeboid forms and multiplied more slowly in
Jones’ medium. This study also confirms the existence of the
amoeboid B. hominis forms, which could be an indicator of
the pathogenicity of the parasite, as stated in our previous
study (Tan and Suresh 2006a). The present study indicates
the potential usefulness of morphology as an inexpensive
tool for identifying potentially pathogenic isolates of B.
hominis, particularly following in vitro culture.
In in vitro culture, asymptomatic isolates (A1–A10)
grew faster and achieved parasite counts approximately
seven times greater than symptomatic isolates (S1–S10) at
the period of peak growth. The average generation time for
asymptomatic isolates was 9.3±1.6 h (range 6.9–11.7 h),
but the average generation time for symptomatic isolates
af
vf
a 
b 
Fig. 4 Scanning electron micrographs of symptomatic B. hominis
isolate (S1) grown in vitro. a Two types of parasite cells can be seen:
(1) a spherical vacuolar form (vf) and (2) an irregularly shaped,
amoeboid form (af) with a rough surface and projections. b Higher
magnification of a showing a vacuolar form with a rough surface
a 
b 
B 
Fig. 3 Scanning electron micrographs of an asymptomatic isolate of
B. hominis grown in vitro. a Vacuolar form (A3) is covered by a
surface coat. b Higher magnification of a showing a smooth surface
with tiny pores
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was almost twice as long (15.3±4.1 h, range 12.3–26.7 h)
(Table 1). Thus, asymptomatic isolates multiplied at about
twice the rate of symptomatic isolates. The reason for this
remains unclear at present, but asymptomatic and symp-
tomatic isolates may undergo different modes of reproduc-
tion in vitro. If the slower growth rate of symptomatic
isolates in vitro give rise to low numbers of parasites in
vivo, parasites may be less easily detected in stool samples,
particularly if diagnosis is dependent on microscopic
examination alone.
Previously, we described the surface morphology of the
amoeboid form of B. hominis (Tan and Suresh 2006b). In
the present study, we observed that vacuolar forms in
symptomatic isolates showed a rougher surface than that
seen in asymptomatic isolates. Bacteria were seen to adhere
more frequently to the rougher surfaces of symptomatic
isolates (data not shown), suggesting a close association
between the surface coat and adherent bacteria. The major
immune response in Blastocystis-infected patients is prob-
ably against surface coat carbohydrate (Tan et al. 2002),
and humans react to the presence of the surface coat by
producing an IgG2 response, which is significantly stronger
Table 2 Intensity of fluorescence and percentage of fluorescent forms of B. hominis labelled with FITC-labelled lectins
Isolates Fluorescence intensity (% fluorescent forms)
FITC-ConA (2 mg/ml) FITC-HPA (1 mg/ml) FITC-WGA (2 mg/ml)
Tube 1a Tube 2 Tube 1a Tube 2 Tube 1a Tube 2
Asymptomatic isolates
A1 1+ (89) 1+ (95) 1+ (30) 1+ (56) 0 (0) 0 (0)
A3 1+ (100) 1+ (100) 1+ (40) 1+ (68) 0 (0) 0 (0)
A4 1+ (100) 2+ (90) 1+ (64) 1+ (85) 0 (0) 0 (0)
A5 1+ (100) 1+ (96) 1+ (55) 1+ (35) 1+ (35) 1+ (46)
A6 1+ (98) 1+ (100) 1+ (80) 1+ (76) 1+ (26) 1+ (45)
A7 1+ (100) 1+ (97) 1+ (74) 1+ (85) 0 (0) 0 (0)
Symptomatic isolates
S1 2+ (100) 3+ (100) 3+ (98) 3+ (100) 0 (0) 0 (0)
S3 3+ (97) 3+ (95) 3+ (95) 3+ (100) 1+ (65) 1+ (54)
S4 3+ (100) 2+ (100) 3+ (100)b 3+ (100)b 1+ (68) 1+ (60)
S5 3+ (100) 3+ (95) 3+ (100)b 3+ (98)b 1+ (42) 1+ (53)
S8 3+ (95) 3+ (100) 3+ (100)b 3+ (100)b 1+ (74) 1+ (65)
S10 2+ (100) 3+ (98) 3+ (100) 3+ (97) 0 (0) 0 (0)
a All experiments performed in duplicate
b Agglutinated parasites observed.
500bp 
Fig. 6 Examples of PCR products from B. hominis DNA amplified
by sequenced-tagged site (STS) primers. Lane 1=DNA size markers
of a 100-bp DNA ladder plus (Fermentas, USA); lanes 2 and 3=
subtype 1 (351 bp); lanes 4 and 5=subtype 2 (650 bp); lanes 6 and 7=
subtype 3 (526 bp)
Fig. 5 Epifluorescence images of FITC-labelled lectin binding B.
hominis assays. A cluster of agglutinated cells showing fluorescence
at the peripheral margin and in the central vacuole using FITC-HPA.
Scale bar=20 μm
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in patients with irritable bowel syndrome as compared with
normal individuals (Hussain et al. 1997).
Several studies have examined the surface morphology
of B. hominis by SEM (Dunn et al. 1989; Boreham and
Stenzel 1993; Suresh et al. 1994; Cassidy et al. 1994;
Zaman et al. 1999). The smooth and pitted surface structure
of B. hominis in asymptomatic isolates is similar to that
described previously by Suresh et al. (1994). The rougher
surface topography of the symptomatic isolates seen in the
present study is comparable to the surface morphology of
the isolate netsky of B. hominis (Boreham and Stenzel
1993), which was isolated from a patient suffering from
diarrhoea in which B. hominis was the only parasite seen
during thorough stool examination (Zierdt and Williams
1974). Hence, the observations in the present study add
further weight to the possible relationship between surface
morphology and the pathogenic potential of B. hominis;
however, its significance remains to be elucidated.
Lanuza et al. (1996) examined 20 symptomatic B.
hominis isolates and described strong binding affinities
between both ConA and HPA and parasite outer surfaces.
ConA exhibits specificity for a-D-mannosyl and a-D-glucosyl
non-reducing terminal groups, HPA specifically binds N-
acetyl-a-D-glucosamine and WGA binds N-acetyl-β-D-
glucosamine (Lanuza et al. 1996). In this study, parasites
from symptomatic isolates consistently showed more
intense surface fluorescence with both FITC-ConA and
FITC-HPA than those from asymptomatic isolates (Table 2).
Thus, our data for symptomatic isolates are in agreement
with those of Lanuza et al. (1996). The presence of N-
acetyl-β-D-glucosamine (detected by WGA) was indicated
in six (50%) of our isolates.
This suggests that the surface coat of parasites from our
symptomatic isolates had higher surface accessible levels of
a-D-mannosyl, a-D-glucosyl non-reducing terminal groups
and N-acetyl-β-D-glucosamine. We also noted differences
in fluorescent lectin binding between and within asymp-
tomatic and symptomatic isolates. Importantly, this is the
first study to identify differences between symptomatic and
asymptomatic isolates in terms of ConA and HPA binding,
suggesting the potential usefulness of both ConA and HPA
in assisting the differentiation of symptomatic and asymp-
tomatic isolates.
Lectin-based studies have been used previously to
identify surface-exposed carbohydrates associated with
pathogenicity. Differences in surface properties were shown
between Entamoeba histolytica isolated from carriers and
those obtained from individuals with invasive amoebiasis
(Martínez-Palomo et al. 1973; Trissl et al. 1977). Patho-
genic strains of E. histolytica were agglutinated more easily
with ConA than isolates from human asymptomats (Trissl
et al. 1977). Virulent strains of E. histolytica produce an
abundance of lipophosphoglycan (LPG) and lipophospho-
peptidoglycan (LPPG), while avirulent E. histolytica and E.
dispar produce either very low or no detectable levels of
LPG, and either low levels or modified forms of LPPG on
their cell surfaces (Moody et al. 1997). In Acanthamoeba
keratitis, lectin-mediated adhesion to host cells is a
prerequisite for amoeba-induced cytolysis of target cells
(Cao et al. 1998).
Sugar inhibition assays revealed that Acanthamoeba
lectin has the highest affinity for α-Man and Man(α1–3)
Man units and in vitro cytopathic assays indicated that
mannose-based saccharides, which inhibited amoeba adhe-
sion to corneal epithelial cells, were also potent inhibitors
of amoeba-induced cytopathic effect (Cao et al. 1998).
Perhaps, as for Acanthamoeba, the adhesion of B. hominis
to enterocytes is also carbohydrate-mediated. The higher
level of a-D-mannosyl, a-D-glucosyl non-reducing terminal
groups and N-acetyl-β-D-glucosamine in parasites from
symptomatic isolates, particularly in amoeboid forms, may
facilitate the adhesion of these parasites to enterocytes,
resulting in gastrointestinal illness. This hypothesis remains
to be elucidated further.
Our previous phylogenetic analyses, based on arbitrarily
primed polymerase chain reaction fingerprinting, using the
same isolates (Tan et al. 2006) indicated that all symptomatic
isolates (S1–S8) formed a clade with >70% similarity among
the isolates and which were clearly separated from asymp-
tomatic isolates A1, A3, A4, A5, A6 and A7. Asymptomatic
isolate A8 formed a distinct clade. The results of our
sequenced-tagged site primer-PCR subtype analysis of these
isolates further support these findings. All symptomatic
isolates (S1–S8) belonged to the same subtype (subtype 3),
while all asymptomatic isolates, except A8, belonged to
subtype 1. Isolate A8 belonged to subtype 2.
Yoshikawa et al. (2004) compared isolates from 15
symptomatic and 11 asymptomatic patients in Bangladesh
using PCR-based subtype classification and found subtypes
1 and 3 in both symptomatic and asymptomatic cases,
indicating a lack of correlation between specific subtypes
and the pathogenic potential of B. hominis. Nevertheless,
results from the present study indicate that subtype 3
correlated with disease, as all symptomatic isolates were
subtype 3. This result contradicts the report by Yan et al.
(2006) who suggested a possible relationship between
subtype 1 and pathogenic potential, although they also
found subtype 3 in symptomatic patients. More recently,
Katsarou-Katsari et al. (2008) concurred with our findings
in that a patient infected with Blastocystis sp. subtype 3
presented with acute urticaria and gastrointestinal symp-
toms. The particular B. hominis isolate was found to
produce throughout in vitro cultivation.
The small-subunit (SSU) ribosomal RNA (rRNA) se-
quence divergence between ribodeme 2 (subtype 3) and
ribodeme 1 (subtype 1) is over 7% (Clark 1997), which is
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approximately four times the genetic distance between the
homologous genes of the pathogen E. histolytica and the
commensal E. dispar (Novati et al. 1996). This may help
explain the remarkable phenotypic differences between
asymptomatic and symptomatic isolates in the present study.
Since B. hominis subtype 3 has been previously reported
from asymptomatic individuals (Yoshikawa et al. 2004; Yan
et al. 2006; Stensvold et al. 2007a), current subtyping
protocols may prove insufficient to determine the patho-
genic potential of this parasite. Additional phenotypic
evidence including the greater size range, the slower growth
rate, the presence of the amoeboid form in in vitro culture,
the strong surface fluorescence of FITC-HPA and FITC-
ConA to in vitro forms and possibly HPA agglutination,
which occurred only in our symptomatic isolates could
assist current genotyping methods in determining the
pathogenic potential of B. hominis.
Molecular phylogenies of Blastocystis from different hosts
based upon the small-subunit (SSU) rRNA and elongation
factor 1α (EF-1α) gene sequences have led to the suggestion
that more than one Blastocystis species can infect humans
(Noël et al. 2005). Based on the phenotypic and genotypic
differences between the asymptomatic and symptomatic
isolates, we identify further phenotypic tools that should
assist in determining the pathogenicity of Blastocystis.
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